Clinical Trials Directory

Trials / Completed

CompletedNCT02818452

Glycemic Impact of Oatmeal Plus OatWellXF28

Affecting the Glycemic Impact of Quaker Instant Oatmeal by Adding OatWell28XF: a Dose-Response Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
40 (actual)
Sponsor
PepsiCo Global R&D · Industry
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Accepted

Summary

The objective of this study is to determine the effect on glycemic responses of adding various doses of OatWell28XF to Quaker Instant Oatmeal in order to: 1) describe the dose-response curve and 2) If possible, identify the minimum level of OatWell28XF which, when added to a serving of Quaker Instant Oatmeal, would result in a glycemic response at least 20% less than that elicited by a β-glucan-free cereal.

Conditions

Interventions

TypeNameDescription
OTHEROatmeal + OatWell28XFIntervention involves consumption of one cereal in the beginning of each visit of the crossover sequence
OTHEROatmeal
OTHERHot cereal

Timeline

Start date
2016-06-01
Primary completion
2016-08-01
Completion
2016-08-01
First posted
2016-06-29
Last updated
2016-12-07

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT02818452. Inclusion in this directory is not an endorsement.